← back to search

Philip H. Li

Queen Mary Hospital · HK
Area of research
Pharmacology · Dermatology
Research interest
Research interests include Drug-Induced Adverse Reactions, Contact Dermatitis and Allergies, Food Allergy and Anaphylaxis Research, and Coagulation, Bradykinin, Polyphosphates, and Angioedema.
h-index
30
citations
7,421
works
233
NIH funding
primary concept
Medicine
email

Recent publications

Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment
Clinical Reviews in Allergy & Immunology 2025cited by 41position: middledoi
Update on the Treatment of Chronic Spontaneous Urticaria
Drugs 2025cited by 29position: middledoi
Unmet needs in hereditary angioedema: an international survey of physicians
Orphanet Journal of Rare Diseases 2025cited by 8position: lastdoi
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab
Allergy and Asthma Proceedings 2025cited by 6position: middledoi
Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
Clinical and Translational Allergy 2025cited by 2position: middledoi
Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study
Allergy 2024cited by 25position: middledoi
Disparities in geography and race in hereditary angioedema: Analysis of 64 trials and 4354 patients
The Journal of Allergy and Clinical Immunology In Practice 2024cited by 10position: lastdoi
Validation and correlations of the Angioedema Activity Score (AAS), Angioedema Quality of Life (AE-QoL) questionnaire, and Angioedema Control Test (AECT) in Chinese patients with angioedema
Journal of Allergy and Clinical Immunology Global 2024cited by 8position: lastdoi
The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation
Clinical & Experimental Allergy 2024cited by 5position: middledoi
Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey
The Journal of Allergy and Clinical Immunology In Practice 2022cited by 37position: firstdoi
The impact of childhood pneumococcal conjugate vaccine immunisation on all-cause pneumonia admissions in Hong Kong: A 14-year population-based interrupted time series analysis
Vaccine 2021cited by 11position: middledoi
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
The Lancet Diabetes & Endocrinology 2019cited by 364position: middledoi
Identifying Low-Risk Beta-Lactam Allergy Patients in a UK Tertiary Centre
The Journal of Allergy and Clinical Immunology In Practice 2019cited by 85position: middledoi
Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infection
British Journal of Radiology 2012cited by 68position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Marcus Maurer · McGill University3 papers (2022–2024)Jie Shen Fok · Monash Medical Centre2 papers (2022–2025) · 2 papers (2024–2024)Maressa Pollen · Jackson Memorial Hospital2 papers (2024–2025)Dinh Van Nguyen · The University of Sydney1 papers (2022–2022)Esther W. Chan · Hong Kong Science and Technology Parks Corporation1 papers (2021–2021) · 1 papers (2022–2022)Mar Guilarte · Hebron University1 papers (2024–2024) · 1 papers (2021–2021)Ivan Fan‐Ngai Hung · Chinese University of Hong Kong1 papers (2021–2021) · 1 papers (2024–2024) · 1 papers (2022–2022)Mark Jit · London School of Hygiene & Tropical Medicine1 papers (2021–2021)Ιάσων Θωμάς · Guy's and St Thomas' NHS Foundation Trust1 papers (2019–2019)Tim J. Craig · University of Bristol1 papers (2024–2024)Petra Staubach · Johannes Gutenberg University Mainz1 papers (2025–2025) · 1 papers (2022–2022) · 1 papers (2025–2025)D-J Su · Harbin Medical University1 papers (2012–2012)Paul K. Keith · Johannes Gutenberg University Mainz1 papers (2024–2024)